Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

11.19 (USD) • At close September 8, 2025
Bedrijfsnaam Ginkgo Bioworks Holdings, Inc.
Symbool DNA
Munteenheid USD
Prijs 11.19
Beurswaarde 662,445,751
Dividendpercentage 0%
52-weken bereik 5 - 16.85
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jason Kelly
Website https://www.ginkgobioworks.com

An error occurred while fetching data.

Over Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products,

Vergelijkbare Aandelen

Teladoc Health, Inc. logo

Teladoc Health, Inc.

TDOC

7.84 USD

Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

INSP

83.55 USD

Perrigo Company plc logo

Perrigo Company plc

PRGO

22.33 USD

Penumbra, Inc. logo

Penumbra, Inc.

PEN

285.59 USD

AMN Healthcare Services, Inc. logo

AMN Healthcare Services, Inc.

AMN

21.04 USD

Bausch + Lomb Corporation logo

Bausch + Lomb Corporation

BLCO

15.52 USD

Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

25.53 USD

Encompass Health Corporation logo

Encompass Health Corporation

EHC

125.96 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)